Andrea Harriott is a Neurology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 77 publications with 1,648 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20258 payments$21,518openpaymentsdata.cms.gov ↗
- Axsome Therapeutics, Inc.Program year20253 payments
- ABBVIE INC.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- The role of oxytocin as an abortive and preventive anti-migraine therapy in a spreading depolarization model of migraine with aura
Massachusetts General Hospital
FY2026$589,105R01NS151782 - Sex Differences in the Role of Gonadal Hormones and the Hypothalamus in Migraine with Aura.
Massachusetts General Hospital
FY2026$227,725K08NS124991 - Sex Differences in the Role of Gonadal Hormones and the Hypothalamus in Migraine with Aura.
Massachusetts General Hospital
FY2025$229,885K08NS124991
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model
International Journal of Pharmaceutics
2026 - Small-molecule CGRP antagonist atogepant does not affect cortical spreading depression susceptibility in rats
The Journal of Headache and Pain
2025 - Oral atogepant mitigates spreading depolarization-induced pain and anxiety behavior in mice
The Journal of Headache and Pain
2025 - Is canonical SD a clinically relevant model of migraine? Argument pro
The Journal of Headache and Pain
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Flaherty, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Andrew Zhu, MD, PhD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Richard Lipton, MD
Albert Einstein College of Medicine
Bradley Boeve, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”